{
    "key_points": [
        "COVID-19 vaccines are increasingly authorized for use in children, with several receiving emergency use authorization in different countries.",
        "The greatest burden of COVID-19 remains among older persons and those with comorbidities; WHO prioritizes vaccination for these groups.",
        "Children and adolescents generally experience milder symptoms of COVID-19 compared to adults.",
        "Children under the age of five years have a higher risk of diseases with symptoms similar to COVID-19.",
        "Children and adolescents can experience 'long COVID-19' and a rare hyperinflammatory syndrome (PIMS-TS/MIS-C) post-infection.",
        "Risk factors for severe COVID-19 in children include older age, obesity, and preexisting conditions.",
        "Evidence suggests that there may be a larger impact of paediatric COVID-19 related fatality in low to middle income countries.",
        "Studies on the role of children and adolescents in COVID-19 transmission have produced mixed results.",
        "Younger children may be less infectious than adolescents and adults.",
        "The socio-economic impact of the COVID-19 pandemic and response on children and adolescents is significant."
    ],
    "spokespersons": [],
    "article_type": "government agency statement",
    "dateline": "",
    "audience": "general public",
    "stance": "neutral"
}